TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07697456: A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Sponsor: AbbVie · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 2000 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$8,349,000

Rescue Site Savings

+$5,520,000

Unlock Full NCT07697456 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07697456 Rescue Dossier →